USP Drug Classification

[ Brite menu | Download htext ]
    

1st Level  2nd Level  3rd Level  4th Level 

 Analgesics
 
 Anesthetics
 
 Anti-Addiction/Substance Abuse Treatment Agents
 
 Antibacterials
 
 Anticonvulsants
 
 Antidementia Agents
 
 Antidepressants
 
 Antiemetics
   Emetogenic Therapy Adjuncts
   Antiemetics, Other
     Chlorpromazine [DG:DG00867]
     Diphenhydramine [DG:DG00390]
     Doxylamine Succinate/Pyridoxine Hydrochloride
     Hydroxyzine [DG:DG00912]
     Meclizine [DG:DG01106]
     Metoclopramide [DG:DG00055]
       D00726  Metoclopramide (JP17/INN)
       D02213  Metoclopramide hydrochloride (JAN)
       D05008  Metoclopramide hydrochloride (USAN)
     Perphenazine [DG:DG00875]
     Prochlorperazine [DG:DG00876]
     Promethazine [DG:DG00385]
     Scopolamine [DG:DG00065]
     Trimethobenzamide [DG:DG01671]
 
 Antifungals
 
 Antigout Agents
 
 Anti-inflammatory Agents
 
 Antimigraine Agents
 
 Antimyasthenic Agents
 
 Antimycobacterials
 
 Antineoplastics
 
 Antiparasitics
 
 Antiparkinson Agents
 
 Antipsychotics
 
 Antispasticity Agents
 
 Antivirals
 
 Anxiolytics
 
 Bipolar Agents
 
 Blood Glucose Regulators
 
 Blood Products/Modifiers/Volume Expanders
 
 Cardiovascular Agents
 
 Central Nervous System Agents
 
 Dental and Oral Agents
 
 Dermatological Agents
 
 Electrolytes/Minerals/Metals/Vitamins
 
 Gastrointestinal Agents
   Antispasmodics, Gastrointestinal
   Histamine2 (H2) receptor Antagonists
   Irritable Bowel Syndrome Agents
   Laxatives
   Protectants
   Proton Pump Inhibitors
   Gastrointestinal Agents, Other
     Alvimopan
     Crofelemer
     Difenoxin hydrochloride and Atropine sulfate
     Diphenoxylate hydrochloride and Atropine sulfate
     Loperamide [DG:DG00092]
     Methylnaltrexone
     Metoclopramide [DG:DG00055]
       D00726  Metoclopramide (JP17/INN)
       D02213  Metoclopramide hydrochloride (JAN)
       D05008  Metoclopramide hydrochloride (USAN)
     Metreleptin
     Rifaximin
     Ursodiol
     Naloxegol
     Glutamine
     Somatropin
     Teduglutide
 
 Genetic or Enzyme Disorder: Replacement, Modifiers, Treatment
 
 Genitourinary Agents
 
 Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
 
 Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
 
 Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins)
 
 Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
 
 Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)
 
 Hormonal Agents, Suppressant (Adrenal)
 
 Hormonal Agents, Suppressant (Pituitary)
 
 Hormonal Agents, Suppressant (Thyroid)
 
 Immunological Agents
 
 Inflammatory Bowel Disease Agents
 
 Metabolic Bone Disease Agents
 
 Ophthalmic Agents
 
 Otic Agents
 
 Respiratory Tract/Pulmonary Agents
 
 Skeletal Muscle Relaxants
 
 Sleep Disorder Agents

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: July 12, 2017
According to the USP Medicare Model Guidelines v7.0

» Japanese version